Patents Assigned to RETINOL SOLUTIONS LLC
  • Methods and compositions for genetic and retinal disease
    Patent number: 9114078
    Abstract: An inventive method for treatment or prevention of vascular diseases of the retina is provided. A Norrin compound is optionally administered to a subject either directly and/or as expressed by a cell. The presence of the compound is either protective of or therapeutic for a pathological condition of the retina. Preferred pathological conditions are those linked to the absence of or mutation of norrin protein and are preferably Norrie disease, FEVR, or macular degeneration.
    Type: Grant
    Filed: March 17, 2009
    Date of Patent: August 25, 2015
    Assignee: RETINOL SOLUTIONS LLC
    Inventor: Kimberly Drenser